Applied Molecular Transport

OverviewSuggest Edit

Applied Molecular Transport (AMT) is a biopharmaceutical company. It develops an oral biological therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases.
TypePublic
Founded2015
HQSouth San Francisco, CA, US
Websiteappliedmt.com

Latest Updates

Employees (est.) (Mar 2020)49
Job Openings24
Share Price (Sept 2021)$30.1
Cybersecurity ratingCMore

Key People/Management at Applied Molecular Transport

Liz Bhatt

Liz Bhatt

Chief Business and Strategy Officer
Bittoo Kanwar

Bittoo Kanwar

Chief Medical Officer
Tahir Mahmood

Tahir Mahmood

CEO & Co-Founder, Director
Earl Douglas

Earl Douglas

Executive Vice President, General Counsel
Shawn Cross

Shawn Cross

Chief Financial Officer
Brandon Hants

Brandon Hants

Vice President, Finance and Business Operations
Show more

Applied Molecular Transport Office Locations

Applied Molecular Transport has an office in South San Francisco
South San Francisco, CA, US (HQ)
1 Tower Pl #850
Show all (1)

Applied Molecular Transport Financials and Metrics

Applied Molecular Transport Revenue

USD

Net income (Q1, 2021)

(20.5m)

EBIT (Q1, 2021)

(20.5m)

Market capitalization (6-Sept-2021)

1.2b

Closing stock price (6-Sept-2021)

30.1

Cash (31-Mar-2021)

26.2m

EV

1.1b
Applied Molecular Transport's current market capitalization is $1.2 b.
Annual
USDFY, 2020

General and administrative expense

12.7m

R&D expense

53.9m

Operating expense total

66.7m

EBIT

(66.7m)
Quarterly
USDQ2, 2020Q1, 2021

General and administrative expense

2.5m5.6m

R&D expense

12.8m14.9m

Operating expense total

15.3m20.5m

EBIT

(15.3m)(20.5m)
Annual
USDFY, 2020

Cash

5.8m

Prepaid Expenses

1.3m

Current Assets

131.5m

PP&E

8.4m
Quarterly
USDQ2, 2020Q1, 2021

Cash

23.4m26.2m

Prepaid Expenses

1.8m2.6m

Current Assets

165.6m112.0m

PP&E

6.8m7.0m
Annual
USDFY, 2020

Net Income

(66.6m)

Depreciation and Amortization

1.8m

Accounts Payable

840.0k

Cash From Operating Activities

(58.9m)
Quarterly
USDQ2, 2020Q1, 2021

Net Income

(30.7m)(20.5m)

Depreciation and Amortization

576.0k784.0k

Accounts Payable

553.0k(1.3m)

Cash From Operating Activities

(28.6m)(20.9m)
USDQ2, 2020

Financial Leverage

1 x
Show all financial metrics

Applied Molecular Transport Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Applied Molecular Transport Online and Social Media Presence

Embed Graph

Applied Molecular Transport News and Updates

Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors

SOUTH SAN FRANCISCO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry veteran to its Board of Directors.

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord …

Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress

Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal calprotectin, CRP, and histology

Applied Molecular Transport to Present at JMP Securities Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the JMP Se…

Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the Jefferi…

Applied Molecular Transport to Present at BofA Securities 2021 Health Care Conference

SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Se…
Show more

Applied Molecular Transport Blogs

AMT-101, a Gut Selective Oral IL-10 fusion: Results from a Phase 1b Study in Patients with Active Ulcerative Colitis

Maximillian Posch, Raisa Tanase, Konstantine Maisaia, Alina Jucov, Christian Geier, Drew Hotson, Omar Hamdy, J. Andrew Whitney, Marvin Garovoy, Bittoo Kanwar, and Stefan SchreiberPoster at 16th Congress of European Crohn’s and Colitis Organisation (ECCO), July 2021 The post AMT-101, a Gut Selective …

Associate Director/Director for Statistical Programming

AMT is looking for an Associate Director/Director for Statistical Programming who will manage the CROs, provide hands-on programming support to AMT’s programs as well as contribute to the development of AMT’s statistical programming (SP) function.  The title will be commensurate with experience.   T…

Associate Director/Director of Clinical Data Management

The Associate Director/Director of Clinical Data Management will lead and manage the CROs, provide hands-on Clinical Data Management (CDM) support to AMT’s programs as well as contribute to the development of AMT’s CDM function.  The title will be commensurate with experience.  The individual will b…

Sr. Process Engineer, Upstream

We are a clinical-stage biopharmaceutical company with a transformative technology platform that is driving the creation and development of a deep pipeline of oral biological therapeutics. We apply foundational scientific principles with the prospect of transforming the biologics landscape and servi…

Inventory Control Specialist

Maintains optimum inventory levels to ensure on-time supply to meet manufacturing requirements. Responsible for continuing programs of exploration for new materials, suppliers, and processes to achieve the best possible quality, reliability, prices, and continuity.  Establishes procedures and superv…

Research Associate, Pharmacology/Biology

We are currently seeking a Research Associate to join our team. This individual will be motivated and thrives as part of cross-functional team within Applied Molecular Transport. This an exciting opportunity for an individual motivated to see his work directly impact the development of our lead mole…
Show more

Applied Molecular Transport Frequently Asked Questions

  • When was Applied Molecular Transport founded?

    Applied Molecular Transport was founded in 2015.

  • Who are Applied Molecular Transport key executives?

    Applied Molecular Transport's key executives are Liz Bhatt, Bittoo Kanwar and Tahir Mahmood.

  • How many employees does Applied Molecular Transport have?

    Applied Molecular Transport has 49 employees.

  • Who are Applied Molecular Transport competitors?

    Competitors of Applied Molecular Transport include Polyplus-transfection, Corvidia and Orum Therapeutics.

  • Where is Applied Molecular Transport headquarters?

    Applied Molecular Transport headquarters is located at 1 Tower Pl #850, South San Francisco.

  • Where are Applied Molecular Transport offices?

    Applied Molecular Transport has an office in South San Francisco.

  • How many offices does Applied Molecular Transport have?

    Applied Molecular Transport has 1 office.